Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HZNP | RPRX | BIIB | ||
| Company | Horizon Therapeutics | Royalty Pharma Plc Cl A | Biogen Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 116.34 | 48.60 | 176.29 | ||
| High | 116.38 | 49.00 | 178.00 | ||
| Low | 116.26 | 48.35 | 175.84 | ||
| Latest | 116.30 | 49.01 | 177.32 | ||
| Change | +0.05 | +0.53 | +1.30 | ||
| % Change | +0.04% | +1.09% | +0.74% | ||
| Volume | 28,881,200 | 498,451 | 258,576 | ||
| 20-Day Average Volume | 3,994,490 | 2,993,381 | 1,285,998 | ||
| Previous Close | 116.25 | 48.48 | 176.02 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 115.61 | 47.49 | 180.59 | ||
| 20-Day Raw Stochastic | 95.09% | 93.19% | 34.95% | ||
| 20-Day Relative Strength | 80.29 | 62.50 | 46.03 | ||
| Weighted Alpha | +49.30 | +55.14 | +42.36 | ||
| Today's Opinion | 88% Buy | 100% Buy | 8% Buy | ||
| Previous Opinion | 88% Buy | 100% Buy | 8% Buy | ||
| Last Month's Opinion | 40% Buy | 88% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.53% since 09/28/23 | +1.81% since 04/10/26 | +2.27% since 04/10/26 | ||
| Low | 115.66 on 09/29/23 | 47.81 on 04/13/26 | 171.22 on 04/13/26 | ||
| High | 116.38 on 10/05/23 | 49.01 on 04/14/26 | 181.77 on 04/14/26 | ||
| 1-Month | |||||
| %Chg | +0.68% since 09/05/23 | +5.76% since 03/17/26 | -4.53% since 03/17/26 | ||
| Low | 114.75 on 09/11/23 | 44.73 on 03/20/26 | 168.64 on 04/06/26 | ||
| High | 116.38 on 10/05/23 | 49.06 on 04/02/26 | 192.27 on 03/26/26 | ||
| 3-Month | |||||
| %Chg | +12.95% since 07/05/23 | +23.30% since 01/16/26 | +7.59% since 01/16/26 | ||
| Low | 98.80 on 08/03/23 | 38.86 on 01/20/26 | 160.36 on 01/20/26 | ||
| High | 116.38 on 10/05/23 | 49.06 on 04/02/26 | 202.41 on 02/06/26 | ||
| 6-Month | |||||
| %Chg | +7.70% since 04/05/23 | +31.76% since 10/17/25 | +23.71% since 10/17/25 | ||
| Low | 90.56 on 05/16/23 | 35.92 on 10/28/25 | 138.00 on 10/30/25 | ||
| High | 116.38 on 10/05/23 | 49.06 on 04/02/26 | 202.41 on 02/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 26,632,118 | 27,966,028 | 25,832,520 | ||
| Shares Outstanding, K | 228,995 | 576,857 | 146,759 | ||
| Annual Sales | 3,629,040,000 | 2,378,190,000 | 9,890,600,000 | ||
| Annual Net Income | 521,480,000 | 770,950,000 | 1,292,900,000 | ||
| Last Quarter Sales | 944,960,000 | 621,990,000 | 2,279,400,000 | ||
| Last Quarter Net Income | 127,070,000 | 214,210,000 | -48,900,000 | ||
| 60-Month Beta | 1.03 | 0.39 | 0.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.20 on 08/08/23 | 1.46 on 02/11/26 | 1.99 on 02/06/26 | ||
| Latest Earnings Date | 11/01/23 | 05/14/26 | 04/29/26 | ||
| Most Recent Dividend | N/A | 0.235 on 02/20/26 | N/A | ||
| Next Ex-Dividends Date | N/A | 02/20/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 25.89 | 10.08 | 11.81 | ||